Perceptive Advisors »

Belite Bio shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.7M 50k 74.00

More positions owned by Perceptive Advisors

Rhythm Pharmaceuticals (RYTM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arcellx Common Stock (ACLX)
Celcuity (CELC)
Nuvalent Inc-a (NUVL)
Merus N V (MRUS)
Amylyx Pharmaceuticals (AMLX)
Roivant Sciences SHS (ROIV)
Meiragtx Holdings (MGTX)
Insmed Com Par $.01 (INSM)
Travere Therapeutics (TVTX)
CryoLife (AORT)
Praxis Precision Medicines I Com New (PRAX)
Immatics SHS (IMTX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Perceptive Advisors

Top funds holding Belite Bio

RA Capital Management
Rtw Investments
Vestal Point Capital
Soleus Capital Management
Eventide Asset Management
Marshall Wace
Perceptive Advisors
Millennium Management
Geode Capital Management
State Street Corporation
Bnp Paribas Arbitrage, Snc
UBS Group
Citadel Advisors
Jpmorgan Chase & Co
Polymer Capital Management

View all funds holding Belite Bio